Herpes simplex and aphthous ulcerations: Presentation, diagnosis and management - An update

General Dentistry

Volumn 51, Issue 6, 2003, Pages 510-516

  Sciubba, James J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10 UNDECENOIC ACID; ACICLOVIR; ANESTHETIC AGENT; ANTIVIRUS AGENT; BEHENYL ALCOHOL; BENZOCAINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CORTICOSTEROID; DAPSONE; DEXAMETHASONE; FAMCICLOVIR; GLUCOCORTICOID; HYDROXYPROPYLCELLULOSE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENCICLOVIR; PENTOXIFYLLINE; POTASSIUM CHANNEL BLOCKING AGENT; SUNSCREEN; TETRACAINE; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE; VALACICLOVIR; CELLULOSE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; LOCAL ANESTHETIC AGENT;

APHTHOUS STOMATITIS; APHTHOUS ULCER; AUTOIMMUNITY; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG EFFICACY; GINGIVA DISEASE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; LOW DRUG DOSE; MOUTH MUCOSA; REVIEW; VIROLOGY; ARTICLE; DIFFERENTIAL DIAGNOSIS; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE; STOMATITIS;

ANESTHETICS, LOCAL; ANTIVIRAL AGENTS; CELLULOSE; DIAGNOSIS, DIFFERENTIAL; HERPES LABIALIS; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOUTH MUCOSA; RECURRENCE; STOMATITIS, APHTHOUS; STOMATITIS, HERPETIC;

EID: 1842486153     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Miller MF, Ship II. A retrospective study of the prevalence and incidence of recurrent aphthous ulcers in a professional population, 1958-1971. Oral Surg Oral Med Oral Pathol 1977;43:532-537.
2. Miller CS, Danaher RJ, Jacob RJ. Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence. Crit Rev Oral Biol Med 1998;9:541-562.
3. Scott DA, Coulter WA, Lamey PJ. Oral shedding of herpes simplex virus type 1: A review. J Oral Pathol Med 1997;26:441-447.
4. Sawtell NM. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol 1997;71:5423-5431.
5. Buske-Kirschbaum A, Geiben A, Wermke C, Pirke KM, Hellhammer D. Preliminary evidence for Herpes labialis recurrence following experimentally induced disgust. Psychother Psychosom 2001;70:86-91.
6. Greenberg MS, Friedman H, Cohen SG, Oh SH, Laster L, Starr S. A comparative study of herpes simplex infections in renal transplant and leukemic patients. J Infect Dis 1987;156:280-287.
7. Heineman HS, Greenberg MS. Cell-protective effect of human saliva specific for herpes simplex virus. Arch Oral Biology 1980;25:257-261.
8. Embil JA, Stephens RG, Manual FR. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 1975;113:627-630.
9. Corey L, Spear PG. Infections with herpes simplex viruses (1). N Engl J Med 1986;314:686-691.
10. Spruance SL, Overall JC Jr, Kern ER, Krueger GG, Pliam V, Miller W. The natural history of recurrent herpes simplex labialis: Implications for antiviral therapy. N Engl J Med 1977;297:69-75.
11. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-1449.
12. Guinan ME, MacCalman J, Kern ER, Overall JC Jr, Spruance SL. Topical ether and herpes simplex labialis. JAMA 1980;243:1059-1061.
13. Freeman DJ, Wenerstrom G, Spruance SL. Treatment of recurrent herpes simplex labialis with topical butylated hydroxytoluene. Clin Pharmacol Ther 1985;38:56-59.
14. Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med 1993;118:268-272.
15. Pope LE, Marcelletti JF, Katz LR, Lin JY, Katz DH, Parish ML, Spear PG. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process. Antiviral Res 1998;40:85-94.
16. Information packet: Abreva docosanol 10% topical cream. San Diego, CA: Avanir Pharmaceuticals;2000.
17. Pope LE, Marcelletti JF, Katz LR, Katz DH. Anti-herpes simplex viral activity of n-docosanol correlates with intracellular metabolic conversion of the drug. J Lipid Res 1996;37:2167-2178.
18. Alrabiah FA, Sacks SL. New antiherpesvirus agents. Their targets and therapeutic potential. Drugs 1996;52:17-32.
19. Habbema L, De Boulle K, Roders GA, Katz DH. n-docosanol 10% cream in the treatment of herpes labialis: A randomized, double-blind, placebo controlled study. Acta Derm Venereol 1996;76:479-481.
20. Sacks SL, Thisted RA, Jones TM, Barbarash RA, Mikolich DJ, Ruoff GE, Jorizzo JL, Gunnill LB, Katz DH, Khalil MH, Morrow PR, Yakatan GJ, Pope LE, Berg JE; Docosanol 10% Cream Study Group. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001;45:222-230.
21. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA 1997;277:1374-1379.
22. Kaminester LH, Pariser RJ, Pariser DM, Weiss JS, Shavin JS, Landsman L, Haines HG, Osborne DW. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis. J Am Acad Dermatol 1999;41:996-1001.
23. Schindl A, Neumann R. Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study. J Invest Dermatol 1999;113:221-223.
24. Shafran SD, Sacks SL, Aoki FY, Tyrrell DL, Schlech WF 3rd, Mendelson J, Rosenthal D, Gill MJ, Bader RL, Chang I. Topical undecylenic acid for herpes simplex labialis: A multicenter, placebo-controlled trial. J Infect Dis 1997;176:78-83.
25. Hirschmann JV. Antimicrobial prophylaxis in dermatology. Semin Cutan Med Surg 2000;19:2-9.
26. Huff JC. Erythema multiforme and latent herpes simplex infection. Semin Dermatol 1992;11:207-210.
27. Ship II. Socioeconomic status and recurrent aphthous ulcers. J Am Dent Assoc 1966;73:120-123.
28. Crivelli MR, Aguas S, Adler I, Quarracino C, Bazerque P. Influence of socioeconomic status on oral mucosa lesion prevalence in schoolchildren. Community Dent Oral Epidemiol 1988;16:58-60.
29. MacPhail LA, Greenspan D, Feigal DW, Lennette ET, Greenspan JS. Recurrent aphthous ulcers in association with HIV infection. Description of ulcer types and analysis of T-lymphocyte subsets. Oral Surg Oral Med Oral Pathol 1991;71:678-683.
30. Muzyka B, Glick M. Major aphthous ulcers in patients with HIV disease. Oral Surg Oral Med Oral Pathol 1994;77:116-129.
31. Boulinguez S, Reix S, Bedane C, Debrock C, Bouyssou-Gauthier ML, Sparsa A, Le Brun V, De Vencay P, Bernard P, Bonnetblanc JM. Role of drug exposure in aphthous ulcers: A case-control study. Br J Dermatol 2002;143:1261-1265.
32. Shotts RH, Scully C, Avery CM, Porter SR. Nicorandil-induced severe oral ulceration: A newly recognized drug reaction. Oral Surg Oral Med Oral Pathol Radiol Endod 1999;87:706-707.
33. Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 1987;110:43-46.
34. Notani K, Kobayashi S, Kondoh K, Shindoh M, Ferguson MM, Fukuda H. A case of Sweet's syndrome (acute febrile neutrophilic dermatosis) with palatal ulceration. Oral Surg Oral Med Oral Pathol Radiol Endod 2000;89:477-479.
35. Shohat-Zabarski R, Kalderon S, Klein T, Weinberger A. Close association of HLA-B51 in persons with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1992;74:455-458.
36. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: A consensus approach. J Am Dent Assoc 2003;134:200-207.
37. Axell T, Henricsson V. Association between recurrent aphthous ulcers and tobacco habits. Scand J Dent Res 1985;93:239-242.
38. Grady D, Ernster VL, Stillman L, Greenspan J. Smokeless tobacco use prevents aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1992;74:463-465.
39. Rennie JS, Reade PC, Hay KD, Scully C. Recurrent aphthous stomatitis. Br Dent J 1985;159:361-367.
40. Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:141-147.
41. Vincent SD, Lilly GE. Clinical, historic, and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol 1992;74:79-86.
42. Porter SR, Kingsmill V, Scully C. Audit of diagnosis and investigations in patients with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1993;76:449-452.
43. Blackwell PJ, Hill PG, Holmes GK. Autoantibodies to human tissue transglutaminase: Superior predictors of coeliac disease. Scand J Gastroenterol 2002;37:1282-1285.